Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.
about
Leber hereditary optic neuropathy: current perspectivesTreatment strategies for inherited optic neuropathies: past, present and futureMitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.The neuro-ophthalmology of mitochondrial diseaseLeber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to Bedside.LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile.Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual systemTreatment of Leber hereditary optic neuropathyLeber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.Grand rounds: could occupational exposure to n-hexane and other solvents precipitate visual failure in leber hereditary optic neuropathy?Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus.Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)A retrospective analysis of characteristics of visual field damage in patients with Leber's hereditary optic neuropathy.Inherited mitochondrial optic neuropathies.Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy.Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.Therapeutic strategies for Leber's hereditary optic neuropathy: A current update.Bilateral progressive visual loss in an epileptic, mentally retarded boy.Leber Hereditary Optic Neuropathy: Exemplar of an mtDNA Disease.The therapeutic potential of a calorie-restricted ketogenic diet for the management of Leber hereditary optic neuropathy.Expert opinion: sexual intercourse followed by headache and transient monocular visual loss.Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathy.Leber's hereditary optic neuropathy (LHON) in an Apulian cohort of subjects.Leber’s Hereditary Optic NeuropathyCurrent and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature
P2860
Q26863599-BAAEDFCF-1777-45DE-B24E-EBAC8A95F998Q33595163-F153D837-E892-433D-AB2B-7EEA79E8F70DQ34152110-1833C559-F7A9-427D-B2E4-B7A820C1E1ACQ34203428-43A3722B-275D-47C0-B17D-F2D9BD1158AAQ34338783-044E837D-EB39-4E7D-B76F-5800681B856CQ34495453-88F55015-D852-459A-AA80-6A13D5A9BC82Q34600009-080E959D-6E80-45D8-BF99-682C79F12F7CQ34898118-54CE8CD8-BAA1-4B9B-8B1C-9761A5E61C65Q35452117-6F85C461-DDDE-4E6E-A738-0F41669FE648Q35561447-FF2B8994-77ED-42A8-B0DF-235913F37DCAQ35636297-DA33E23C-F381-44CC-8047-319240277E93Q36202218-F9E209CC-7AC4-4E63-8AE8-C6AF80BB40E4Q37021025-1D87EB7E-933D-4CB1-BC19-4889E59A7244Q37034023-79B16FDA-CBBA-43A9-8F1B-42C893BAA262Q37098009-328450C3-637A-4CAB-A285-01A8DB378D91Q37577287-40A691E2-2CDF-487B-B9C8-BEEA0EF942B6Q37618929-4D89128E-01A7-49BA-8FF4-20858F41C4CFQ39108502-3B0A3CE2-F747-4FDD-B47F-CD27F893227AQ42118874-27385162-FF76-4026-82DC-1D88F001F54AQ45865052-56B07013-41B4-4BAF-BDF2-1A17909FE348Q46289935-F79DC7DC-85EA-48DE-B4BD-7FB9373CEEF2Q46673706-A9DE1CC2-A939-410E-B351-A2E86392ABEAQ49900516-9F2D0354-7233-494E-B327-55A1CC5FAAB5Q55260081-847210E1-C002-4F54-A599-FBE66D7127C0Q57721071-F4C5F0F8-C55C-41A7-B1CD-639389D56BCCQ58772307-34C7FAD3-0CF5-4CE4-AF10-BCE0A76FD17B
P2860
Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@ast
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@en
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@nl
type
label
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@ast
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@en
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@nl
prefLabel
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@ast
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@en
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@nl
P2093
P1476
Prophylaxis for second eye inv ...... of topical brimonidine purite.
@en
P2093
Bradley K Farris
Kuankuan Chen
M Tariq Bhatti
Nancy J Newman
Robert David
Robert L Lesser
Robert P Keaney
Roger E Turbin
Steven A Newman
Steven R Hamilton
P304
P356
10.1016/J.AJO.2005.03.058
P407
P577
2005-09-01T00:00:00Z